ALVAC-DC is a product line of therapeutic cancer vaccines that combines the best of classical and oncolytic immunotherapy with recombinant DNA / RNA technology.

The flagship ALVAC-DC combines the best of classic cancer vaccines with recombinant RNA / DNA technology

ALVAC-DC is a patient-friendly vaccine that is well-suited for a wide range of cancer diagnoses. The patient’s own Antigen Presenting Cells (APC) are boosted by recombinant DNA / RNA. The product is expected to be very effective, and with few side effects.